



- Stock: In Stock
- Model: 184844
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Fenilin-Zdorovye tab. of 30 mg No. 20
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
tablets "Fenilin-Zdorovye" are applied at the following indications: prevention and treatment of thromboses (especially deep veins of the lower extremities), tromboembolic episodes (pulmonary embolism, strokes, a myocardial infarction) and a thrombogenesis during the postoperative period at patients with mechanical prostheses of valves of heart.
Structure
Active ingredient - phenindione (one tablet contains Phenilinum (Fenindionum) 30 mg).
Excipients: lactoses monohydrate; potato starch; talc; citric acid, monohydrate.
Contraindication
- hypersensitivity to medicament components;
- hemophilia;
- threat of termination of pregnancy;
- big postoperative wounds;
- bleeding from digestive organs, breath, an urinogenital system;
- recently postponed surgical interventions or injuries of a head/spinal cord, an eye;
- recently carried out lumbar anesthesia, a biopsy of a liver or kidneys;
- heavy liver and/or renal failure;
- hemorrhagic diathesis; hypocoagulation (initial level of a prothrombin is less than 70%);
- erosive cankers of a digestive tract;
- heavy arterial hypertension;
- a state at which therapy cannot be carried out rather safely (for example psychoses, dementia, alcoholism).
by
to adults and children is more senior than 14 years (with body weight not less than 45 kg) inside after a meal.
Dose is established by the doctor individually taking into account sensitivity to drug, the nature of a disease, feeding habits and the accompanying treatment.
byAdult to appoint in the first day of treatment in a daily dose 120-180 mg (4-6 tablets) in 3-4 receptions, in the second day - in a daily dose of 90-150 mg (3-5 tablets), then - on 30-60 mg (1-2 tablets) in 1-2 inclusion depending on prothrombin level in blood.
byto Children aged from 14 years (with body weight not less than 45 kg) to appoint in the first and second days of treatment in a daily dose 90-150 mg (3-5 tablets) in 3-4 receptions, then - on 30-60 mg (1-2 tablets) in 1-2 inclusion depending on prothrombin level in blood.
Single dose, frequency and duration of use are established individually by the doctor depending on value of the prothrombin ratio of blood which is supported at the level of 40-60%. At prothrombin level less than 40-50% medicament should be cancelled immediately.
to appointFor prevention of tromboembolic episodes on 30 mg (one tablet) 1-2 times a day.
highest doses for adults: single - 50 mg, daily - 200 mg.
should Cancel medicament gradually.
toPregnant
toDrug is contraindicated to
Feature of use
during pregnancy (especially in the I trimester and in the second half of the III trimester). Drug should not be used in the first days after the delivery. In need of medicament use the feeding by a breast should be stopped. byChildren
Drug to appoint to children aged from 14 years with body weight not less than 45 kg.
Drivers
during treatment should abstain from control of motor transport and potentially dangerous types of activity demanding the increased concentration of attention and speed of psychomotor reactions.
Overdose
Symptoms: a hemorrhagic syndrome (gastrointestinal, uterine, nasal bleedings, a hamaturia, hemorrhages in skin, muscles, parenchymatous bodies).
Treatment: medicament withdrawal intake of vitamin K in (5-10 mg). At development of serious bleedings to appoint vitamin K intravenously slowly (1 mg/minute) in the general dose of 10-50 mg (normalizes the raised prothrombin time within 6 hours). In massive bleeding or the patient with a liver failure at the same time to appoint freshly frozen plasma. Use of aminocapronic acid, vitamins C and R.
is possibleSide effects
from the coagulant system of blood: at prolonged use - a micro and gross hematuria, bleeding from an oral cavity and a nasopharynx, gastrointestinal bleedings, hemorrhage in muscles.
from blood: oppression of a marrowy hemopoiesis (agranulocytosis, leukopenia, leukemoid tests).
from digestive system: nausea, vomiting, diarrhea, a sore throat, taste disorders, stomatitis, toxic hepatitis, jaundice, ulcer colitis, paralytic Ilheus with an abdominal distension.
from a cardiovascular system: myocarditis.
Allergic reactions: skin rashes (erythematic, macular, papular), exfoliative dermatitis, eosinophilia, hyperthermia, massive hypostasis, skin necrosis.
from an urinary system: a renal failure, coloring of urine in pink color, an albuminuria.
Storage conditionsto Store
in original packing at a temperature not above 25 °C, out of children's reach.
Expiration date - 3 years.
Specifications
Characteristics | |
Active ingredients | Fenindionum |
Amount of active ingredient | 30 mg |
Applicant | Health |
Code of automatic telephone exchange | B01AA02 Fenindionum |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | TOB PHARMACEUTICAL COMPANY HEALTH |
Quantity in packing | 20 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 8 °C to 25 °C |
Trade name | Phenilinum |